Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer

Nutrition and Cancer

Volumn 60, Issue 3, 2008, Pages 325-330

  Stratton, Steven P ^a,b   Saboda, Kathy Lynn ^b   Myrdal, Paul B ^b   Gupta, Abhishek ^c   McKenzie, Naja E ^b   Brooks, Chris ^b   Salasche, Stuart J ^b   Warneke, James A ^a   Ranger Moore, James ^d   Bozzo, Paul D ^b   Blanchard, James ^d   Einspahr, Janine G ^a   Dorr, Robert T ^a   Levine, Norman ^a   Alberts, David S ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NEKTAR THERAPEUTICS   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERILLYL ALCOHOL; PLACEBO;

ADULT; ARTICLE; BURN; CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOREARM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACULOPAPULAR RASH; MALE; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; PRURITUS; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; SUN; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADULT; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; MONOTERPENES; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 42649142587     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701840391     Document Type: Article

References (18)

1. Gould MN: Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 105(Suppl4), 977-979, 1997.
2. Barthelman M, Chen W, Gensler HL, Huang C, Dong Z, et al.: Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res 58, 711-716, 1998.
3. Lluria-Prevatt M, Morreale J, Gregus J, Alberts DS, Kaper F, et al.:Effects of perillyl alcohol on melanoma in the TPras mouse model. Cancer Epidemiol Biomarkers Prev 11, 573-579, 2002.
4. Mills JJ, Chari RS, Boyer IJ, Gould MN, and Jirtle RL: Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55, 979-983, 1995.
5. Crowell PL: Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129, 775S-778S, 1999.
6. Hohl RJ and Lewis K: Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270, 17508-17512, 1995.
7. Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, et al.: Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res 6, 390-396, 2000.
8. Hakim IA, Harris RB, and Ritenbaugh C: Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer 37, 161-168, 2000.
9. Gupta A and Myrdal PB: Development of a perillyl alcohol topical cream formulation. Int J Pharm 269, 373-383, 2004.
10. Gupta A, Stratton SP, and Myrdal PB: An HPLC method for quantitation of perillyl alcohol in a topical pharmaceutical cream formulation. J Pharm Biomed Anal 37, 447-452, 2005.
11. Bozzo P, Saboda K, Einspahr JG, Ranger-Moore J, Farmer ER, et al.: Reliability and validity of a histologic score as a marker for skin cancer chemoprevention studies. Anal Quant Cytol Histol 25, 285-292, 2003.
12. Plewis I: Ways of measuring change. In: Analyzing Change: Measurement and Explanations Using Longitudinal Data. New York: Wiley & Sons, Inc., pp. 16-29, 1985.
13. Marks R: An overview of skin cancers: incidence and causation. Cancer 75, 607-612, 1995.
14. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute: Cancer Progress Report 2003 Update (NIH Publication No. 02 - 5045). Bethesda, MD: National Institutes of Health, 2003.
15. Burren R, Scaletta C, Frenk E, Panizzon RG, and Applegate LA: Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations. Int J Cancer 76, 201-206, 1998.
16. de Gruijl FR: Photocarcinogenesis: UVA vs. UVB. Methods Enzymol 319, 359-366, 2000.
17. Runger TM: Role of UVA in the pathogenesis of melanoma and nonmelanoma skin cancer: a short review. Photodermatol Photoimmunol Photomed 15, 212-216, 1999.
18. Swerdlow AJ and Weinstock MA: Do tanning lamps cause melanoma? an epidemiologic assessment. J Am Acad Dermatol 38, 89-98, 1998.